Cartesian Therapeutics Inc (RNAC)
Stock-Based Compensation
$9.24M
TTM · Period ending: · USD
RNAC Stock-Based Compensation
Latest reported$9.24Mperiod ending
Latest reported$9.24Mperiod ending
RNAC TTM Stock-Based Comp ($1.13M → $9.24M)
TTM stock-based compensation
High-resolution chart · PNG
RNAC stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 9,240,000 | |
| 10,436,000 | |
| 10,521,000 | |
| 10,242,000 | |
| 9,347,000 | |
| 7,659,000 | |
| 6,582,000 | |
| 22,115,000 | |
| 22,741,000 | |
| 24,933,000 | |
| 25,778,000 | |
| 10,656,000 | |
| 10,936,000 | |
| 10,717,000 | |
| 11,194,000 | |
| 11,171,000 | |
| 10,474,000 | |
| 8,693,000 | |
| 7,720,000 | |
| 6,703,000 | |
| 6,095,000 | |
| 5,793,000 | |
| 5,422,000 | |
| 5,613,000 | |
| 5,620,000 | |
| 5,390,000 | |
| 5,161,000 | |
| 5,524,000 | |
| 5,706,000 | |
| 5,741,000 | |
| 5,714,000 | |
| 5,133,000 | |
| 4,962,000 | |
| 4,541,000 | |
| 4,081,000 | |
| 3,642,000 | |
| 2,960,000 | |
| 2,462,000 | |
| 2,051,000 | |
| 1,537,000 | |
| 1,157,000 | |
| 1,105,000 | |
| 1,125,000 |